U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $ 7,000 out of pocket to treat their condition each year. And even though drug companies have provided no new treatment breakthroughs, the price of these disease-modifying medications has been rising by 10 to 15% each year for the past decade. To find out… Read More »
The health care market in the United States is opaque. Most people don’t know the costs of medical procedures they need until after the fact, leaving patients with little to no ability to factor price into their health care decisions. In an effort to change this, CBS News is working on a series of reports… Read More »
Sen. Amy Klobuchar, D-Minn., said Friday that the Obama administration missed the chance to put Big Pharma in its place when it drafted Obamacare. “I would have liked to see this be part of the Affordable Care Act,” Klobuchar said of drug pricing measures in an appearance on CNN. “But it wasn’t, in part because… Read More »
Health and Human Services Secretary Alex Azar had a stern warning for the pharmaceutical industry on Friday, a day after the Trump administration proposed a plan to change the way Medicare pays for certain expensive drugs.
Democrats reacted with skepticism this week when President Trump decided to embrace a policy they favor and install price controls on certain Medicare drugs, a reaction that reflects the lingering resentment from 2017’s bruising fight over Obamacare repeal. Trump broke with traditional Republican policy when he announced a proposal Thursday to tie reimbursement for certain… Read More »